2 - 5 April 2026, Athenaeum Intercontinental, Αthens. IASIS PHARMA participated in the 21st Panhellenic Conference of Dermatology & Venereology «The Skin Enigma» held on 2 to 5 April 2026, at the Athenaeum Intercontinental hotel. The conference was organized by the Hellenic Society of Dermatology and Venereology. Many Dermatologists attended the congress and had the chance to [...]
18 – 21/03/2026 Divani Caravel Hotel, Athens. IASIS PHARMA participated at the “24th PANHELLENIC DIABETES CONGRESS”, held in Athens, at the Divani Caravel Hotel, showing its active interest in Diabetes Mellitus disease. Moreover, IASIS PHARMA is about to invest significantly in T2DM by launching original products in oral liquid forms. The conference took place from March 18 to 21, 2026, with the participation of [...]
12 – 14/02/2026 THE MET, Thessaloniki. IASIS PHARMA participated at the “Panhellenic Seminars of the Cardiology Working Groups”, held in Thessaloniki, at the Met Hotel, from February 12 to 14, 2026. In IASIS PHARMA exhibition stand, the following products were presented: RosuZet®: New Product Launching. Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single dosage form, [...]
12 - 13/12/2025, Eugenides Foundation (Planetarium), Athens During 12 - 13/12/2025, the 24th Dermatological Conference "Skin, Kaleidoscope of Health" took place at Planetarium/Athens. Greek Dermatologists who attended the conference visited IASIS PHARMA exhibition stand to get informed of the IASIS Dermatological products: Isotroin®/ Isotretinoin, (at the new & unique 30mg dosage) indicated for severe forms of Acne that [...]
5–6/12/2025 Divani Caravel Hotel/ Athens. IASIS PHARMA participated in the 11th Panhellenic Conference of Working Groups organized by the Hellenic Atherosclerosis Society. The conference was held from 05 to 06/12/2025, at the Divani Caravel Hotel in Athens, with the participation of many Healthcare Professionals. Participants had the opportunity to learn more about the high-quality pharmaceutical [...]
19 - 23/11 2025 Athenaeum InterContinental, Athens During 19 - 23/11 2025, at Athenaeum InterContinental / Athens, the Hellenic Dermatology & Venereology Society together with the Dermatology & Venereology Society of Cyprus organized the 3rd Panhellenic Conference of Dermatology and Venerology. Greek Dermatologists who attended the congress visited IASIS PHARMA exhibition stand to get informed of the IASIS Dermatological [...]
06/11 – 08/11 2025, Makedonia Palace, Thessaloniki IASIS PHARMA participated in the “25th PANHELLENIC CONGRESS OF HYPERTENSION” which was held from 06/11 to 08/11 2025, at the Makedonia Palace Hotel/Thessaloniki. The conference was organized by the Hellenic Society of Hypertension (HSH). IASIS PHARMA presented at its exhibition stand the following products: RosuZet®: New Product Launching. Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single dosage form, in packages [...]
23-26/10/2025 Conference Center of the University of Patras, City of Patras IASIS PHARMA participated with great success for another year in the 45th Pan-Hellenic Gastroenterology Conference, which was held under the auspices of the Hellenic Gastroenterological Society (EGE), at the Conference Center of the University of Patras, on 10/23/25 – 10/26/2025. IASIS PHARMA presented the unique herbal medicine Mastiha var. Chia, [...]
23 – 25/10/2025, Megaron The Athens Cocert Hall IASIS PHARMA participated in the “46th PANHELLENIC CONGRESS OF CARDIOLOGY” which was held from 23/10 to 25/10 2025, at the Megaron the Athens Concert Hall. The conference was organized by the Hellenic Society of Cardiology (HSC). The Panhellenic Congress of Cardiology has established among Cardiologists and the Pharmaceutical Industry, as the Scientific Conference par excellence, with the largest [...]
4 – 6/09/2025 Elite City Resort, Kalamata IASIS PHARMA participated at the “18th Panhellenic Conference on Cardiometabolic Risk Factors”, held exclusively in person at the Elite City Resort Hotel/Kalamata, from September 4 to 6, 2025. In IASIS PHARMA exhibition stand, the following products were presented: RosuZet®: New Product Launching. Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single dosage form, in packages of [...]
